StonvexLoading…
StonvexStonvexStonvexCore line items from THRY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $149.03M | $167.68M | $785.01M | $593.40M | $391.84M |
Operating Income | Not available | $4.06M | $56.71M | $46.55M | $26.51M |
Net Income | Not available | $4.54M | $307.00K | $9.97M | $4.31M |
EPS (Diluted) | $-0.10 | $0.10 | $0.01 | $0.22 | $0.10 |
Total Assets | Not available | $693.74M | $688.59M | $701.80M | $687.70M |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $7.95M | $10.75M | $11.55M | $10.84M |
Free Cash Flow OCF − CapEx | Not available | $-5.45M | $31.14M | $18.83M | $4.22M |
Shares Outstanding | Not available | 44.34M | 43.82M | 43.57M | 43.93M |